Cite
Safety and Efficacy of Hypofractionated Radiotherapy Combined with Tyrosine Kinase Inhibitors in Patients with Lung Metastases after Liver Transplantation for Hepatocellular Carcinoma.
MLA
Zhuang, Y., et al. “Safety and Efficacy of Hypofractionated Radiotherapy Combined with Tyrosine Kinase Inhibitors in Patients with Lung Metastases after Liver Transplantation for Hepatocellular Carcinoma.” International Journal of Radiation Oncology, Biology, Physics, vol. 117, no. 2, Oct. 2023, p. e360. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2023.06.2448.
APA
Zhuang, Y., Chen, Y., Du, S., Hu, Y., & Zeng, Z. C. (2023). Safety and Efficacy of Hypofractionated Radiotherapy Combined with Tyrosine Kinase Inhibitors in Patients with Lung Metastases after Liver Transplantation for Hepatocellular Carcinoma. International Journal of Radiation Oncology, Biology, Physics, 117(2), e360. https://doi.org/10.1016/j.ijrobp.2023.06.2448
Chicago
Zhuang, Y., Y. Chen, S. Du, Y. Hu, and Z.C. Zeng. 2023. “Safety and Efficacy of Hypofractionated Radiotherapy Combined with Tyrosine Kinase Inhibitors in Patients with Lung Metastases after Liver Transplantation for Hepatocellular Carcinoma.” International Journal of Radiation Oncology, Biology, Physics 117 (2): e360. doi:10.1016/j.ijrobp.2023.06.2448.